MAZE
Maze Therapeutics, Inc.
26.10$
-0.6%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| – | – | – | -247.4% | |
| – | +7.0% | -19.4% | -27.1% | |
| – | +29.9% | +10.3% | +70.0% | |
| – | – | – | – | |
| – | -77.6% | +160.1% | -30.8% | |
| – | -86.1% | +160.1% | +14,805.1% | |
| – | – | – | – | |
| – | – | +51.3% | -100.0% | |
| – | +848.2% | +466.7% | +196.5% | |
| – | – | – | -104.5% | |
| – | – | – | -250.7% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.